Skip to main navigation
Neoleukin Therapeutics

Investors

Financial and Filings

Financial and Filings

PFIC Letter 2014 216.3 KB
Show all

2021

First Quarter
  • Earnings Press Release
  • Form 10-Q

2020

Fourth Quarter
  • Earnings Press Release
  • Form 10-K
Third Quarter
  • Earnings Press Release
  • Form 10-Q
Second Quarter
  • Earnings Press Release
  • Form 10-Q
First Quarter
  • Earnings Press Release
  • Form 10-Q

2019

Fourth Quarter
  • Form 10-K
Third Quarter
  • Form 10-Q
Second Quarter
  • Form 10-Q
First Quarter
  • Form 10-Q

2018

Fourth Quarter
  • Form 10-K
Third Quarter
  • Form 10-Q
Second Quarter
  • Form 10-Q
First Quarter
  • Form 10-Q

Proxy Statements

Filing date View
March 31, 2021
0001193125-21-102235.pdf
0001193125-21-102235.rtf
0001193125-21-102235.xls
View HTML

In This Section

  • Financial and Filings
  • SEC Filings
  • Annual Reports
  • Quarterly Results

Investor Tools

  • Investor FAQs
  • Contact IR
  • Email Alerts

Neoleukin - Investors Menu (Secondary)

  • Press Releases
  • Events & Presentations
  • Financial and Filings
  • Stock Information
  • Analysts
  • Corporate Governance

Neoleukin - Investor Relations

  • About
    • Vision
    • Leadership
    • Board of Directors
    • Contact
  • Science
    • De Novo Protein Design
    • Neoleukin Platform
    • Publications
    • Collaborations & Partnerships
  • Programs
    • NL-201
    • Research
  • News
    • Press Releases
    • Events
    • In The News
    • Media Contact
  • Investors
    • Press Releases
    • Events & Presentations
    • Financial and Filings
    • Stock Information
    • Analysts
    • Corporate Governance
    • Investor FAQs
    • Contact IR
    • Email Alerts
  • Careers
    • Overview
    • Job Opportunities
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Twitter
  • Neoleukin TherapeuticsHome

    • Neoleukin - Investor Relations

  • About
    • Vision
    • Leadership
    • Board of Directors
    • Contact
  • Science
    • De Novo Protein Design
    • Neoleukin Platform
    • Publications
    • Collaborations & Partnerships
  • Programs
    • NL-201
    • Research
  • News
    • Press Releases
    • Events
    • In The News
    • Media Contact
  • Investors
    • Press Releases
    • Events & Presentations
    • Financial and Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Stock Information
    • Analysts
    • Corporate Governance
    • Investor FAQs
    • Contact IR
    • Email Alerts
  • Careers
    • Overview
    • Job Opportunities
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Twitter
©  Neoleukin Therapeutics, Inc. All rights reserved.
  • Twitter
  • Privacy Policy
  • Terms & Conditions